GO
Loading...

Geron Corp

More

  • The halt announced on Thursday was for enrollments in a trial sponsored by Mayo Clinic, and comes a week after the FDA ordered Geron to cease company-sponsored trials of the drug over similar concerns. The FDA on March 12 had ordered a complete halt to trials that were testing imetelstat to treat thrombocythemia and multiple myeloma, two forms of blood cancer.

  • *Fannie Mae, Freddie Mac shares fall on Senate proposal for wind-down. NEW YORK, March 12- U.S. stocks finished little changed on Wednesday, with the Nasdaq up for the first session in five, as investors grappled with the evolving situation in Ukraine but shrugged off concern over weakness in China's economy.

  • *Herbalife shares tumble on FTC investigation. NEW YORK, March 12- U.S. stocks were little changed on Wednesday, as equities recouped much of their earlier declines amid signs of progress in diplomatic attempts to ease tensions in Ukraine.

  • US STOCKS-Wall St pares losses as Ukraine concerns ease Wednesday, 12 Mar 2014 | 12:26 PM ET

    NEW YORK, March 12- U.S. stocks were little changed on Wednesday, as equities recouped much of their earlier declines amid signs of progress in diplomatic attempts to ease tensions surrounding Ukraine.

  • US STOCKS-Wall St declines on China, Ukraine concerns Wednesday, 12 Mar 2014 | 10:40 AM ET

    *EPL Oil to be acquired by Energy XXI for $2.3 bln. NEW YORK, March 12- U.S. stocks declined on Wednesday, putting the S&P 500 on track for a third straight decline after its most recent record high, as concerns grew over the strength of China's economy. London copper, seen as a proxy for China's economic health, fell for a fourth day to its lowest level since July 2010.

  • US STOCKS-Wall St to open lower as China concerns mount Wednesday, 12 Mar 2014 | 8:53 AM ET

    *EPL Oil to be acquired by Energy XXI for $2.3 bln. NEW YORK, March 12- U.S. stocks were poised to fall at the open, putting the S&P 500 on track for a third straight decline, as concerns grew over the strength of China's economy.

  • March 12- Geron Corp said the U.S. Food and Drug Administration ordered a halt to trials of its cancer drug imetelstat over concerns about potential liver damage, sending the company's shares plunging almost 60 percent before the bell.

  • Nov 7- Geron Corp said 22 percent of trial patients treated with its experimental blood cancer drug were now free of the disease, a major break for the company after two big setbacks. Shares of Geron more than doubled in morning trade on Thursday to a four-year high. Geron earlier failed to develop the blood cancer drug, imetelstat, to treat breast cancer.

  • After-Hours Buzz: INTC, AXP & More Thursday, 17 Jan 2013 | 4:38 PM ET

    Check out which companies are making headlines after the bell Thursday:

  • After-Hours Buzz: ORCL, GERN & More Monday, 3 Dec 2012 | 4:44 PM ET

    Check out which companies are making headlines after the bell Monday.

  • BioTime makes offer for Geron stem cell assets Thursday, 18 Oct 2012 | 12:36 AM ET

    In a letter to Geron shareholders, BioTime suggests two deals that would form a new publicly traded company owning Geron's stem cell assets with some of BioTime's. It said Geron could have a stake of up to 45 percent in the company, which would also hold $40 million in BioTime stock along with shares of some BioTime stem cell subsidiaries.

  • 5 Stocks Under $10 Set to Spike Higher Friday, 20 Apr 2012 | 1:49 PM ET
    NYSE

    Here’s a look at several under-$10 stocks that look poised to trade higher from current levels.

  • Cramer makes the call on viewers' favorite stocks.

  • Lightning Round OT: Ashland, Quantum and More Wednesday, 26 Jan 2011 | 7:24 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • When Will Apple Reach $300? Monday, 16 Aug 2010 | 7:31 PM ET

    Plus, get calls on small-cap tech, dry-bulk shippers and more.

  • Lightning Round: Citigroup, Garmin, Celgene and More Thursday, 1 Oct 2009 | 9:24 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Pops & Drops: Agilent, Palm... Tuesday, 18 Aug 2009 | 6:00 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Agilent and Palm popped while Geron and GameStop dropped.

  • Cramer makes the call on viewers' favorite stocks.

  • Lightning Round OT: Cephalon, CIT Group and More Wednesday, 10 Jun 2009 | 9:05 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • The Latest Picks That Paid - Friday May 15th Friday, 15 May 2009 | 6:01 PM ET
    Quicker Ticker

    Our traders are good but you knew that. Check out their latest picks that paid in a feature we call “Quicker Than The Ticker.”

Most Popular Video

Thursday, 17 Apr 2014 | 5:00 AM ET

Today is CNBC's 25th anniversary. There have been a lot of great moments in the network's history. Here are just a few.

Thursday, 17 Apr 2014 | 3:15 AM ET

Jonny Forsyth, global drinks analyst at Mintel, says China has been a "cash cow" for drink-makers, but the slowdown is having a big impact on sales.

Thursday, 17 Apr 2014 | 1:35 AM ET

CNBC's Helia Ebrahimi discusses the Co-Operative's troubled story from drug buying allegations against the former chairman, to big financial black holes.